It remains unclear whether the efficacy of R59022 and R59949 on leukemia cells is due to off-target effects, such as those reported on serotonin receptors [33], or to a broader activity on other DGK isoforms at the relatively high concentrations used in this study. This evidence concerns the gene DGKE and leukemia.